TBCH (NASDAQ) insider resale notice; director sold 19,902 shares on Mar 23, 2026

Rhea-AI Filing Summary

Treasury BioClinic Holdings (TBCH) reported proposed sales of restricted common stock via a Form 144 notice. The filing lists two restricted-stock lots dated 04/01/2025 for 1,845 shares and 04/01/2026 for 5,000 shares. It also records recent reported dispositions by Katherine Scherping of 19,902 shares on 03/23/2026 for $231,221.44 and 98 shares on 03/20/2026 for $1,127.00.

Insights

Securities Compliance Counsel

Form 144 lists proposed sales of restricted common stock and recent dispositions.

The filing identifies two lots of restricted stock (1,845 shares dated 04/01/2025 and 5,000 shares dated 04/01/2026) and recent reported sales by Katherine Scherping totaling 20,000 shares across two trades.

Timing, placement method, and any resale restrictions are not stated in the excerpt; subsequent SEC filings or broker confirmations would clarify execution details.

Key Figures

Restricted shares (04/01/2025): 1,845 shares Restricted shares (04/01/2026): 5,000 shares Sale by Katherine Scherping (03/23/2026): 19,902 shares +3 more

6 metrics

Restricted shares (04/01/2025) 1,845 shares Restricted Stock dated 04/01/2025

Restricted shares (04/01/2026) 5,000 shares Restricted Stock dated 04/01/2026

Sale by Katherine Scherping (03/23/2026) 19,902 shares Reported sale on 03/23/2026

Proceeds from 03/23/2026 sale $231,221.44 Proceeds reported for 19,902-share disposition

Sale by Katherine Scherping (03/20/2026) 98 shares Reported sale on 03/20/2026

Proceeds from 03/20/2026 sale $1,127.00 Proceeds reported for 98-share disposition

Key Terms

Restricted Stock, Form 144, Proceeds

3 terms

Restricted Stock financial

"Common | 04/01/2025 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Form 144 regulatory

"CONTENT METADATA includes "form_type": "144""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Proceeds financial

"03/23/2026 | 19902 | 231221.44"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6845	89659.91	19847421	05/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2025	Restricted Stock	Issuer			1845	04/01/2025	Not Applicable
Common	04/01/2026	Restricted Stock	Issuer			5000	04/01/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KATHERINE SCHERPING 15822 Bernardo Center Drive, Suite 105 San Diego CA 92127	Common	03/23/2026	19902	231221.44
KATHERINE SCHERPING 15822 Bernardo Center Drive, Suite 105 San Diego CA 92127	Common	03/20/2026	98	1127.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TBCH Form 144 disclose about shares to be sold?

The filing discloses proposed sales of restricted common stock: 1,845 shares dated 04/01/2025 and 5,000 shares dated 04/01/2026. These lots are identified as restricted stock held by an issuer.

Who reported recent sales in the TBCH filing and how many shares were sold?

Katherine Scherping reported recent dispositions of 19,902 shares on 03/23/2026 and 98 shares on 03/20/2026, with proceeds reported as $231,221.44 and $1,127.00, respectively.

Are the securities listed in the TBCH excerpt restricted or free-trading?

The excerpt explicitly labels the two lots as Restricted Stock, dated 04/01/2025 and 04/01/2026. The filing does not state whether resale conditions or holding-period expirations have been satisfied.

Does the Form 144 state how the shares will be sold (method or timing)?

The provided excerpt does not specify the sale method or timing. It lists the securities and recent past sales but does not include details on placement, brokers, or conditional timing within the visible text.

What proceeds were reported for the recent TBCH transactions?

Reported proceeds in the excerpt are $231,221.44 for the 19,902-share sale on 03/23/2026 and $1,127.00 for the 98-share sale on 03/20/2026; no other proceeds amounts are shown in the excerpt.